This analysis examines the current position and future outlook for Merck KGaA in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-7 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
Reasons to Purchase
Assess the continued impact of Glucophage’s patent expiry on Merck KGaA’s therapeutic focus
Benchmark Merck KGaA’s performance against key rivals in the ethical pharmaceutical sector
Understand the potential of Merck KGaA’s developing oncology portfolio
